Capture the full market potential
Peter Hackel, CFO
Flims, 17 January 2020
Capture the full market potential Peter Hackel, CFO Flims, 17 - - PowerPoint PPT Presentation
Capture the full market potential Peter Hackel, CFO Flims, 17 January 2020 Looking back Financial performance Q3 2019 and our track record 2 Strong momentum sustained over nine months; full-year revenue target raised REVENUE REVENUE
Peter Hackel, CFO
Flims, 17 January 2020
2
REVENUE REVENUE GROWTH REGIONAL DRIVERS
CHF 1.2bn
+16% vs 9M 2018 FX headwind CHF 20m Acquisition effect: CHF 14m Q3: +19% organic, +21% in CHF Q2: +16% organic; +14% in CHF Q1: +17% organic; +15% in CHF generate 68% of 9M growth; NAM edges ahead of APAC as fastest growing region
BUSINESS DRIVERS INVESTMENTS OUTLOOK2
BLT & BLX, clear aligners, value brand rollouts, supply agreements with DSOs Distribution JV in Hong Kong & Macau; Korean implants; Implant & clear aligner production Full-year organic revenue growth in the mid- teen percentage range
3
1 Organic growth – i.e. excluding the effects of currency fluctuations and acquired/divested business activities 2 Outlook expectations barring unforeseen events/circumstances
4
20.2 14.4 56.7 57.6 37.9 15.7 1’151.1
Revenues 9M 2019 Revenues 9M 2018 North America FX effect APAC
989.0
EMEA
983.2
LATAM Revenues 9M 2018 @ FX 2019 M&A effect
16.4% CHF 17.1%
Revenue development (CHFm, rounded)
Change in organic growth
19.9% 18.1% 13.5% 20.4%
34% 34% 23% 9%
LATAM APAC North America EMEA
Regional share of
9.1 13.1 15.7 18.9 16.3
2015 2016 2017 2018 H1 2019
27.6% 28.3% 29.3% 29.6% 31.5%
100 200 300 400 2015 2016 2017 2018 H1 2019
EBITDA excl. exceptionals Exceptionals Underlying margin
5-year organic revenue growth 5-year EBITDA1 (in CHF m) and margin
Market growth est. 4-5%
Av e r a g e + 1 5 % + 3 . 9 % - p o i n t s
5 1 Adjusted for non-recurring or exceptional effects if applicable.
Total solution provider tooth replacement Total solution provider esthetic dentistry
2012 2016 2018
Implant provider 3.4
Addressable market in CHF billion
7.0 14.0
7
Preventive dentistry represents ~2bn market opportunity
Market segments
(2018 in CHF bn)
Growth rate Our current market share Biomaterials 0.7 High-single digits Implantology1 4.5 Mid-single digits CAD/CAM equipment2 1.5 Double digits CAD/CAM prosthetics 3.9 Double digits
(All ceramic)
Clear aligners 2.6 >25%
1 Imaging and planning segment is not included in the overview above. Customized prosthetics are listed under CAD/CAM prosthetics, but also belong to
the total implant and abutment market.
8
9
Implant volumes in key markets (million units in 2017)
1.5 1.2 1.3 2.4 0.8 1.4 2.7 0.2 0.4 1.4 0.3 SPAIN ITALY GERMANY BRAZIL TURKEY RUSSIA USA UK-IRELAND JAPAN CHINA / HONG KONG INDIA 319 197 160 118 98 160 74 38 33 10 2
Premium Non- Premium
Our new subsidiaries
Penetration: Implants per 10’000 inhabitants
10
12 19
Roxolid implant material
13 14
PURE ceramic 1-piece implant Variobase abutments BLT implant
15 16
ProArch edentulous solution N!ce fully-crystallized glass-ceramic Grand Morse Grand Morse implant Grand Morse Mini implant PURE 2-piece ceramic implant
17 18
BLX implant Small diameter implant ( 2.9mm) Short implant (4mm) Roxolid-on-all Chairside 3D printing
11
Premium Upper value Lower value
Global implant & abutment market
12
Neodent, Anthogyr, Medentika
~CHF 4.5 bn
Straumann Group share (2018)
Zinedent, T-Plus, equinox
▪ Full market release in most key markets except for China, Japan, Russia and Turkey ▪ 70 000 BLX implants sold in in the first 9 months, despite aggressive competitor promotions ▪ Many new customers attracted by BLX who then also bought BLT ▪ Innovative, next-generation BLX implant, priced at a premium to Straumann’s popular BLT range
13
Current Straumann Group market share
Market volume
(Implant fixtures)
25 million units
Parallel walled Apically tapered Fully tapered
Main players:
Nobel Biocare, BioHorizons, MIS, Implant Direct, Megagen Neodent, Anthogyr and Equinox
14
▪ Market worth CHF 2.6bn; expected to grow >25% ▪ 60% case growth in North America in Q3 ▪ Direct-to-patient expected to outpace conventional approach ▪ Partnership with Smyletec to address Chinese market ▪ Production capacity expension in Round Rock (USA) ▪ New production units in Curitiba (Brazil) and Markkleeberg (Germany) ▪ Orthodontic planning service acquired ▪ Orthodontic materials company acquired
15
16
Intra-oral scanning and software appl. Treatment planning 3D model printing Production
Digital Planning Service Private Ltd. Rapidshape
Materials Patient monitoring Brands to address global market Sales network and reach
Dental Monitoring (DenToGo) Global organization to address all customer groups
▪ In 5 years’ time one in two dental clinics is forecast to have an intraoral scanner (IOS) corresponding to a potential market of 300 000 scanners ▪ Approx. 65% of practices expect to invest in a digital impression system in the next 3 years ▪ Orthodontists and implant surgeons have the highest buying intentions
17
100% 50%
Global penetration 18’
13%
15’ 16’17’18’
2024
24’
IOS penetration follows classical S-curve
18
Villeret expansion project to add 16 000 m2 production area (operational early 2021) 2nd plant in Curitiba (Brazil) to add 11 000m2 production space (opening in Q4 2019)
19
VISION More than creating smiles – restoring confidence We want to be the partner of choice in esthetic dentistry CULTURE Player-learner mindset Core behaviors
3 strategic priorities 9 must-win battles >5000 people to make it happen 55 must-win initiatives
STRATEGY HOW WHAT WHY
20